2025-524746-96-00RecruitingPhase 1
Phase 1 Single Dose Study of JADE201 in Participants with Rheumatoid Arthritis
Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 Oct 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- First submitted
- 10 Mar 2026
- Start date
- 5 Aug 2026
- Lead sponsor
- Jade Biosciences Inc.
- Diseases
- Rheumatoid arthritis
- EU CT number
- 2025-524746-96-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 24
- 4 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Multispecialty hospital for active treatment Sveta Sofia EOOD | Sofiya | Bulgaria | Recruiting |
| Charite Research Organisation GmbH | Berlin | Germany | Recruiting |
| Arensia Clinics S.R.L. | Bucharest | Romania | Recruiting |
| Spitalul Clinic Judetean De Urgenta Cluj | Cluj-Napoca | Romania | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.